Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system
by Thabata Martins Ferreira Campuzano, Maria Amelia Carlos Souto Maior Borba, Paula de Mendonça Batista, Michelle Nadalin, Cicera Pimenta Marcelino, Paula Cristina Pungartnik, Angélica Carreira dos Santos, Letícia Paula Leonart Garmatter, Maria Aparecida do Carmo Rego, Angélica Nogueira-Rodrigues
The aim of the study is to evaluate the treatment patterns, time to start treatment, and healthcare resources utilization (HCRU) of cervical cancer (CC) patients within the Brazilian public health system (SUS). This is an observational retrospective study using SUS administrative database (DATASUS). Data from January-2014 to December-2020 was gathered from patients with the ICD-10 C53 codes. From 2014 to 2020, 206,861 women were included, among whom 90,073 (43.5%) had stage information. Of staged patients, 60.7% (54,719) had advanced disease (stages III and IV) and the most performed treatments were chemoradiotherapy (CRT) (41.6%), surgery + CRT (19.1%), radiotherapy (RT) only (16.8%) and chemotherapy (CT) only (13.3%). The proportion of patients submitted to CT in advanced stages was higher than in non-advanced stages (I and II), in contrast to RT, which was more frequent in stage I than stage IV. Median time to initiate treatment surpassed two months in approximately 30% of the cases, regardless of stage. Conization was the most performed surgical procedure. The hospitalization rate per patient per month for stage IV was twice as high as stage I (0.05 [95%CI 0.05–0.05] and 0.11 [0.11–0.11], respectively). The same trend was observed for outpatient visits (0.54 [95%CI 0.53–0.55] and 0.96 [0.93–0.98], respectively). This study demonstrated a high proportion of advanced CC at diagnosis in Brazil. The treatment pattern showed that chemoradiotherapy was the most frequent regimen overall and the use of chemotherapy and HCRU increased with staging. These results could provide information to improve public policies towards access to prevention, diagnosis, and treatment of CC in Brazil.